A Study of Anlotinib in Patients With Gastroenteropancreatic Neuroendocrine Tumor G3
Clinical trial NCT03457844 · UNKNOWN
Trial details
- NCT number
- NCT03457844
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-30
- Primary completion
- 2019-08-30
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.